| Year |
Citation |
Score |
| 2020 |
Findley DL, Berquist MD, Hambuchen MD. Methamphetamine-Induced Open Field Behavior and LD50 in Periplaneta americana Cockroaches (Blattodea: Blattidae). Journal of Economic Entomology. PMID 33146384 DOI: 10.1093/jee/toaa255 |
0.409 |
|
| 2020 |
Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Drug and Alcohol Dependence. 208: 107850. PMID 31954950 DOI: 10.1016/j.drugalcdep.2020.107850 |
0.597 |
|
| 2019 |
Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization. Psychopharmacology. PMID 31729537 DOI: 10.1007/s00213-019-05380-3 |
0.609 |
|
| 2019 |
Bullock TA, Berquist MD, Baker LE. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine. Behavioural Pharmacology. PMID 31268871 DOI: 10.1097/Fbp.0000000000000491 |
0.483 |
|
| 2019 |
Hyatt WS, Berquist MD, Chitre NM, Russell LN, Rice KC, Murnane KS, Fantegrossi WE. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats. Behavioural Pharmacology. PMID 31211703 DOI: 10.1097/Fbp.0000000000000492 |
0.596 |
|
| 2019 |
McClenahan SJ, Hambuchen MD, Simecka CM, Gunnell MG, Berquist MD, Owens SM. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug and Alcohol Dependence. 195: 140-147. PMID 30634109 DOI: 10.1016/J.Drugalcdep.2018.12.006 |
0.314 |
|
| 2018 |
Fantegrossi WE, Wilson CD, Berquist MD. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug Metabolism Reviews. 1-9. PMID 29385930 DOI: 10.1080/03602532.2018.1428343 |
0.583 |
|
| 2017 |
Ford BM, Franks LN, Tai S, Fantegrossi WE, Stahl EL, Berquist MD, Cabanlong CV, Wilson CD, Penthala NR, Crooks PA, Prather PL. Characterization of Structurally Novel G Protein Biased CB1 Agonists: Implications for Drug Development. Pharmacological Research. PMID 28838808 DOI: 10.1016/J.Phrs.2017.08.008 |
0.67 |
|
| 2017 |
Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE. Phencyclidine-like in vivo effects of methoxetamine in mice and rats. Neuropharmacology. PMID 28830759 DOI: 10.1016/J.Neuropharm.2017.08.028 |
0.551 |
|
| 2017 |
Berquist MD, Baker LE. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behavioural Pharmacology. PMID 28598863 DOI: 10.1097/Fbp.0000000000000310 |
0.458 |
|
| 2017 |
Berquist MD, Fantegrossi WE. Discriminative Stimulus Effects of Psychostimulants. Current Topics in Behavioral Neurosciences. PMID 28341944 DOI: 10.1007/7854_2017_5 |
0.656 |
|
| 2016 |
Berquist MD, Traxler HK, Mahler AM, Baker LE. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug and Alcohol Dependence. PMID 27181413 DOI: 10.1016/J.Drugalcdep.2016.05.001 |
0.397 |
|
| 2015 |
Prus AJ, Mooney-Leber SM, Berquist MD, Pehrson AL, Porter NP, Porter JH. The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine. Behavioural Pharmacology. 26: 489-94. PMID 26154437 DOI: 10.1097/Fbp.0000000000000159 |
0.334 |
|
| 2015 |
Berquist MD, Peet MM, Baker LE. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behavioural Pharmacology. 26: 180-3. PMID 25485643 DOI: 10.1097/Fbp.0000000000000121 |
0.43 |
|
| Show low-probability matches. |